CLOSE

Benchmark Investments

DSP Healthcare Fund-Reg(G)

very highequitypharma & health care
43.08 -0.01(-0.02%) NAV as on 21 Oct 2026
-6.52 % 1 M
8.85 % 1 Y
17.74 % 3 Y

Growth Chart of the Scheme vis a vis benchmark

  • 1W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y

SCHEME DETAILS

Expenses Ratio :

2.05

As on 30 Sep, 2026
Age :

7 yrs 10 m

Since 30 11 ,2018
Exit Load :

0.5%

AUM :

3,750.04 Crs

Portfolio Price To Book Value :

6.88

Investing Style :

Mid Growth

Min. Investment :

SIP 100 & Lumpsum 100

Category :

sector funds

Fund Manager :

Chirag Dagli

Launch Date :

30-Nov-18

Scheme Benchmark :

NA

FUND OBJECTIVE

The primary investment objective of the scheme is to seek to generate consistent returns bypredominantly investing in equity and equity related securities of pharmaceutical and healthcarecompanies.

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

LATEST ASSET & PORTFOLIO ALLOCATION

as on Sep 30 ,2026
Others 7.82 %
Equity 92.18 %

TOP HOLDINGS

Ipca Laboratories Ltd.8.13 %
Sun Pharmaceutical Industries...7.44 %
Cipla Ltd.7.18 %
Sai Life Sciences Ltd.6.52 %
Gland Pharma Ltd.6.15 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs64.95
Hospital & Healthcare Services16.49
Business Support1.35
Insurance1.02
Medical Equipment/Supplies/Accessories0.14
See All Sectors

5-YEARS HISTORY

Financial Year2021-20222022-20232023-20242024-20252025-2026
NAV in Rs (as on 31-Mar-2026)21.8820.9132.7637.4036.15
Net Assets(Rs Crores) (as on 31-Mar-2026) 1291.46 1202.10 2352.32 3018.76 2891.76
Scheme Returns(%)(Absolute)13.12-4.6056.8613.41-1.49
B'mark Returns(%)(Absolute)NANANANANA
Category Rank44/7561/7620/9017/10256/120

Quarterly Performance - Last 5 Years (Absolute Ret. In %)

Financial Year Q1 Q2 Q3 Q4
2026-202719.213.48NANA
2025-20264.31-1.301.83-7.80
2024-20251.8822.291.97-10.15
2023-202414.709.6012.5510.74
2022-2023-11.909.134.21-4.59

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

DSP Healthcare Fund-Reg(G)Very HighEquity43.08-0.01(-0.02%)NAV As on 22 Oct, 202630-Nov-2018Inception Date3,750.04AUM In Cr.8.85%1Y17.74%3Y13.47%5Y20.32%Since Inception
HDFC Pharma and Healthcare Fund-Reg(G)Very HighEquity20.06-0.02(-0.11%)NAV As on 22 Oct, 202604-Oct-2023Inception Date3,501.37AUM In Cr.15.35%1Y26.19%3YNA%5Y25.76%Since Inception
UTI Healthcare Fund-Reg(G)Very HighEquity313.17-1.37(-0.44%)NAV As on 22 Oct, 202601-Aug-2005Inception Date1,429.84AUM In Cr.6.49%1Y19.57%3Y13.77%5Y17.61%Since Inception

BENCHMARK INVESTMENTS

Benchmark Investments, 6 Sector II Shanti Niketan, Govindpura Bhopal, Bhopal-462023, India. +91-755-4938282/+91-9826310337 hello@benchmarkinvestments.in.
Downloads
Quick Links
Useful Links

Mutual fund and other investments are always subject to market risks. Please read all, Scheme Information Documents (SID), Key Information Memorandum (KIM), Addendums(if any) issued there to from time to time and any other related documents or information carefully before investing. Past performance is not indicative or assurance of future performance or returns. Please consider your specific investment requirements before choosing a fund.

For any grievances, investors can contact at: hello@benchmarkinvestments.in,  Tel: +91-755-4938282 / +91-9826310337.
©  Copyrights 2022 , Benchmark Investments | All Rights Reserved |  Designed, Developed & Content Powered by Accord Fintech Pvt Ltd